|
5-year biochemical lack of evidence of disease (bNED) in patients treated for prostate cancer with EBRT sorted by 5-level risk stratification, with the hazard ratio of relapse with/without ADT and corresponding p values are generated from the Kaplan-Meier log-rank test. |
||||
| Risk Group |
With ADT |
Without ADT |
Hazard ratio [95% CI] |
P value |
|
|
||||
| Low |
84% |
86% |
1.8 [0.2–16.6] |
n.s |
| Low intermediate |
75% |
70% |
1.1 [0.56–2.1] |
n.s |
| High intermediate |
72% |
55% |
0.57 [0.4–0.83] |
P = 0.0029 |
| High |
64% |
36% |
0.47 [0.33–0.69] |
P = 0.0001 |
| Extreme |
43% |
21% |
0.61 [0.42–0.89] |
P = 0.01 |
Beasley et al. Radiation Oncology 2008 3:8 doi:10.1186/1748-717X-3-8 |
||||